KASLYN MONAH: Open Payments
NPI 1689075715 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,220 in 59 payments from 21 companies in 2025. Trend: 2023 $1,313 · 2024 $2,112 · 2025 $1,220
Food & beverage: $1,220
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $260 |
| Novartis Pharmaceuticals Corporation | 16 | $179 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| UCB, Inc. | 3 | $92 |
| Alexion Pharmaceuticals, Inc. | 3 | $87 |
| Biogen, Inc. | 3 | $62 |
| TG Therapeutics, Inc. | 2 | $60 |
| PFIZER INC. | 2 | $57 |
| SK Life Science, Inc. | 1 | $34 |
| ACADIA Pharmaceuticals Inc | 1 | $32 |
Products named: QULIPTA, KESIMPTA, REXULTI, ULTOMIRIS, BRIUMVI, NURTEC ODT, Leqembi, Zilbrysq.
Industry payments across GA — which companies pay providers there.
